Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions

Iudici, Michèle; Riveros, Carolina; Gabay, Cem; Puéchal, Xavier; Berthelot, Jean-Marie; Ravaud, Philippe

doi:10.1016/j.semarthrit.2019.03.009

Scientific article

Review

English

Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions

ContributorsIudici, Michèle

; Riveros, Carolina; Gabay, Cem; Puéchal, Xavier; Berthelot, Jean-Marie; Ravaud, Philippe

Published inSeminars in Arthritis and Rheumatism, vol. 49, no. 3, p. 453-458

Publication date2019

Abstract

To investigate how the use of pharmacologic concomitant medications (CMs) is planned and reported in rheumatology randomized controlled trials (RCTs).

Keywords

Randomized controlled trial
Rheumatology
Concomitant medications

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

IUDICI, Michèle et al. Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions. In: Seminars in Arthritis and Rheumatism, 2019, vol. 49, n° 3, p. 453–458. doi: 10.1016/j.semarthrit.2019.03.009

Article (Published version)

Identifiers

PID : unige:138658
DOI : 10.1016/j.semarthrit.2019.03.009
PMID : 30975475

Commercial URLhttps://www.sciencedirect.com/science/article/pii/S0049017219300034

ISSN of the journal0049-0172

229views

0downloads

Creation20/07/2020 14:31:00

First validation20/07/2020 14:31:00

Update time15/03/2023 22:20:44

Status update15/03/2023 22:20:42

Last indexation02/10/2024 12:28:52

Archive ouverte UNIGE

Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions

To investigate how the use of pharmacologic concomitant medications (CMs) is planned and reported in rheumatology randomized controlled trials (RCTs).

Technical informations